Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:ALEC
NasdaqGS:ALECBiotechs

Alector (ALEC) Is Down 54.3% After Latozinemab Phase 3 Failure and Major Restructuring – Has The Bull Case Changed?

Earlier this week, Alector and its partner GSK announced that latozinemab failed to meet safety and efficacy criteria in a Phase 3 clinical trial for frontotemporal dementia due to GRN gene mutations, leading to the discontinuation of related studies and a workforce reduction of approximately 49%. This setback not only impacts Alector's core pipeline but also coincides with the resignation of its President and Head of R&D, highlighting significant changes in the company's direction. We'll...
OM:FRACTL
OM:FRACTLTech

Fractal Gaming Group (OM:FRACTL) Earnings Surge 84%, Reinforcing Bullish Narrative on Profit Momentum

Fractal Gaming Group (OM:FRACTL) kept its momentum rolling, with earnings leaping 84% over the past year, far outpacing its five-year annual average of 16.3%. Net profit margin rose to 6.5% from last year’s 4.6%, while shares changed hands at SEK34.3, still beneath the discounted cash flow fair value estimate of SEK42.94. With future earnings expected to grow 24.1% per year and no listed risks, upbeat sentiment is underpinned by robust profit trends, improving margins, and compelling...
NasdaqGS:VMEO
NasdaqGS:VMEOInteractive Media and Services

Vimeo (VMEO): Exploring Valuation After 90% Share Price Rally This Quarter

Vimeo (VMEO) shares have quietly climbed in recent months, gaining over 90% in the past quarter. Investors seem to be taking a closer look at the company’s evolving business and recent annual growth figures. See our latest analysis for Vimeo. After a long stretch of mixed sentiment, Vimeo’s recent share price return of over 90% in the past quarter reflects renewed optimism and upward momentum. This is especially notable considering its 65% total shareholder return over the past year. While...
TSXV:COV
TSXV:COVBiotechs

TSX Penny Stocks To Consider In October 2025

As we approach the end of 2025, the Canadian market remains resilient despite challenges such as trade uncertainties and emerging credit concerns. Investors are encouraged to use market volatility as an opportunity to rebalance and diversify their portfolios, with a focus on quality investments. While penny stocks may sound like a term from a bygone era, they continue to offer potential value for those interested in smaller or newer companies with strong financial foundations. In this...
NasdaqCM:FLUX
NasdaqCM:FLUXElectrical

Is FLUX’s Shelf Registration a Hint at New Growth Strategies or Simply Prudent Funding Flexibility?

In recent days, Flux Power Holdings, Inc. filed a shelf registration statement to potentially offer up to US$19.57 million in common stock, comprising 3,644,289 shares. This move gives the company financial flexibility, potentially signaling preparations for future capital needs, business development plans, or expansion opportunities. We'll examine how the shelf registration could affect Flux Power Holdings' narrative, especially its impact on future funding and growth plans. Find companies...
TSX:TECK.B
TSX:TECK.BMetals and Mining

Teck Resources (TSX:TECK.B) Turns Profitable, Challenging Bearish Narratives on Margins

Teck Resources (TSX:TECK.B) has recently moved into profitability, with evidence of improved net profit margins over the last year. Over the past five years, annual earnings growth averaged -14.1%, making historical comparisons less meaningful now that the company has turned the corner. With no flagged risks and the company trading below an estimated fair value, investors are likely zeroing in on the recent profit turnaround and the perceived value opportunity. However, muted growth forecasts...
ASX:PAR
ASX:PARBiotechs

Can Paradigm Biopharmaceuticals' (ASX:PAR) Leadership Vision Drive Long-Term Strategic Value?

Paradigm Biopharmaceuticals Limited presented at the Ignite Investment Summit in Hong Kong on October 15, 2025, with Founder, MD & Executive Chairman Paul John Rennie delivering key insights. The company's participation at this high-profile investor event provided stakeholders with detailed updates on its strategic direction and executive leadership vision. We'll explore how Paradigm Biopharmaceuticals' focus on its executive leadership vision at the summit shapes its current investment...
NasdaqCM:COYA
NasdaqCM:COYABiotechs

Coya Therapeutics (COYA) Raises $20 Million in Equity Offering Can Fresh Capital Reshape Its Growth Trajectory?

Coya Therapeutics, Inc. has completed a follow-on equity offering worth US$20,000,002, issuing 3,636,364 shares of common stock at US$5.50 per share. This capital raise signals the company’s focus on securing funding for continued development of its therapeutic programs and growth initiatives. With fresh capital in hand, we'll examine how the follow-on equity offering influences Coya Therapeutics' investment narrative and funding outlook. The end of cancer? These 27 emerging AI stocks are...